Related Experiment Video

Updated: Sep 28, 2026

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

Molecular neurotoxicological models of Parkinsonism: focus on genetic manipulation of mice

J L Cadet1

  • 1Molecular Neuropsychiatry Section, National Institutes of Health/National Institute on Drug Abuse, Intramural Research Program, 5500 Nathan Shock Drive, 21224, Baltimore, MD 21224, USA. jcadet@intra.nida.nih.gov

Parkinsonism & Related Disorders
|August 8, 2001
PubMed

Insights

Parkinson's disease involves the loss of dopaminergic cells, primarily due to oxidative stress. Recent research suggests multiple molecular pathways contribute to this neurodegenerative process.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder impacting the nigrostriatal dopaminergic system.
  • The precise cellular and molecular mechanisms underlying PD pathogenesis are still under investigation.

Purpose of the Study:

  • To explore the cellular and molecular pathobiology of Parkinson's disease.
  • To understand the factors contributing to dopaminergic cell death in PD.

Main Methods:

  • Utilized in vitro and in vivo models with toxins to study dopaminergic cell damage.
  • Employed genetically modified mice to investigate gene functions related to PD.
  • Examined the role of oxidative stress in dopaminergic cell demise.

Main Results:

  • Early studies identified oxidative stress as a key factor in dopaminergic cell death.
  • Genetic manipulation studies indicated that multiple molecular pathways, both dependent and independent, converge to cause cell death.
  • Identified trigger events leading to the demise of dopaminergic cells.

Conclusions:

  • Oxidative stress plays a significant role in the pathogenesis of Parkinson's disease.
  • Dopaminergic cell loss in PD results from a complex interplay of molecular pathways.
  • Further research into these pathways may reveal new therapeutic targets for Parkinson's disease.

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

Related Concept Videos

In-vitro Mutagenesis (Gene Knockouts)02:29

In-vitro Mutagenesis (Gene Knockouts)

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...